
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Peganum harmala is a plant containing harmaline and harmine alkaloids that act as monoamine oxidase inhibitors (MAOIs). These compounds increase serotonin, dopamine, and norepinephrine levels by blocking their breakdown, potentially supporting mood regulation.

Reported Benefits (Provisional)
Origin & History

Peganum harmala, commonly known as Harmal or Syrian Rue, is a plant native to the Mediterranean region and parts of Asia. It is traditionally harvested for its seeds, which contain psychoactive alkaloids.
Research Narrative (Provisional)
Some studies have explored the antidepressant and analgesic effects of Peganum harmala, but more research is needed. Randomized controlled trials (RCTs) are limited, and further studies are necessary to confirm its efficacy and safety.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Peganum harmala (Syrian Rue) is not consumed as a food ingredient but as a medicinal/ritual plant; thus conventional macronutrient profiling is not applicable at culinary doses. Bioactive alkaloids dominate its chemical profile. Key compounds include: beta-carboline alkaloids — harmine (0.44–5.6% dry seed weight), harmaline (0.25–4.8% dry seed weight), and harmalol (0.036–0.16% dry seed weight), which are the primary monoamine oxidase inhibiting (MAOI) constituents. Quinazoline alkaloids include vasicine (peganine) (~0.25% dry weight) and vasicinone, associated with bronchodilatory effects. Seeds contain approximately 15–17% fixed oils (fatty acids including linoleic, oleic, and palmitic acids), 12–15% crude protein (amino acid composition not fully characterized), and 5–8% crude fiber. Minerals detected in seed extracts include potassium (~1,200 mg/100g estimated dry weight), calcium (~300 mg/100g), magnesium (~180 mg/100g), iron (~12 mg/100g), and zinc (~3 mg/100g), though bioavailability is considered low due to binding with alkaloids and tannins. Antioxidant phenolic compounds include rutin, quercetin derivatives, and gallic acid at trace levels (50–200 mg/100g total phenolics). Tannin content approximately 2–4% dry weight. Bioavailability note: alkaloid absorption is rapid orally but highly variable; harmine and harmaline cross the blood-brain barrier efficiently. Due to MAOI activity, concurrent consumption with tyramine-rich foods poses hypertensive crisis risk. Toxic threshold is low; medicinal doses typically involve <1g seed material.
Reported Mechanism (Provisional)
Harmaline and harmine alkaloids in Peganum harmala reversibly inhibit monoamine oxidase-A (MAO-A) enzyme, preventing breakdown of serotonin, dopamine, and norepinephrine. This leads to increased neurotransmitter availability in synaptic clefts. The plant also contains quinazoline alkaloids that contribute to antioxidant activity through free radical scavenging.
Clinical Narrative (Provisional)
Most research on Peganum harmala consists of in vitro and animal studies examining its MAOI activity and antioxidant properties. Limited human clinical trials exist, with small-scale studies (n=20-40) showing potential mood benefits, though methodological quality varies. The evidence for antidepressant effects remains preliminary, requiring larger randomized controlled trials. Traditional use data supports its historical application for mood disorders in Middle Eastern medicine.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







